Weight Loss & Metabolic Research Peptides South Africa
Our metabolic range covers the GLP-1 and fat-metabolism compounds most requested by South African research groups. It includes single-agonist and dual-agonist candidates such as Tirzepatide and Retatrutide, amylin analogues like Cagrilintide, and targeted lipolytic candidates including AOD-9604 and HGH Fragment 176-191. Every vial is synthesised to ≥ 97% purity, verified by HPLC and mass spectrometry, and ships with a Certificate of Analysis on request. Orders placed before 2 pm are dispatched the same day from Johannesburg by tracked courier, with local ZAR pricing and no customs delays. Use our free peptide calculator to plan reconstitution volumes before you order.
Research guides for weight loss & metabolic
What Is Tirzepatide? Dual GIP/GLP-1 Agonist Research Guide
How dual incretin receptor agonism differs from single GLP-1 agonism in the metabolic literature.
What Is Retatrutide? Triple Agonist Research Guide
Adding glucagon receptor activity to dual agonism — what the third receptor changes in the literature.
What Is Semaglutide? GLP-1 Agonist Research Guide
The GLP-1 receptor agonist most requested by South African metabolic researchers: structure, mechanism and handling.
Buying research peptides in South Africa
How purity is verified, what batch documentation covers, and how local ordering, payment and courier delivery work.
Read the South Africa guideStudy data for weight loss & metabolic
Retatrutide Research: Trials, Data & What the Studies Show
A trial-by-trial look at what the published Retatrutide literature reports — study design, participant numbers, headline outcomes and links to the sources.
AOD-9604 Research: What the Studies Show
AOD-9604 is one of the few research peptides with a large, properly controlled human dataset — and the honest summary is that the fat-loss effect seen in rodents did not carry over. Here is each study, including the trial that ended its development.
5-Amino-1MQ Research: Studies, NNMT Inhibition & What the Data Shows
Although online research communities group it with peptides, 5-Amino-1MQ is a cell-permeable small-molecule inhibitor. It targets Nicotinamide N-methyltransferase (NNMT), an enzyme heavily active in fat tissue that accelerates metabolic ageing by depleting cellular NAD+.
Tirzepatide Research: SURPASS & SURMOUNT Phase 3 Trial Data
A trial-by-trial look at tirzepatide — the dual GIP/GLP-1 agonist known commercially as Mounjaro and Zepbound — covering the SURPASS diabetes programme, the SURMOUNT obesity programme, cardiovascular data and the documented side-effect profile.
Cagrilintide Research: Trials, Data & What the Studies Show
Cagrilintide is a long-acting amylin analog that works through receptors GLP-1 drugs do not touch. Here is what the published monotherapy and CagriSema combination data actually report.
AICAR Research: Endurance, AMPK Data & What the Studies Show
AICAR is a synthetic cell-permeable nucleoside and a direct activator of AMPK, the body's master metabolic regulator. Nicknamed the 'exercise mimetic', its literature spans cell assays, subcutaneous animal endurance trials, neuro-immunology models and human cardiac surgery data.
Adipotide Research: Mechanism, Primate Data & Kidney Findings
Adipotide (FTPP, proapoptotic peptide) has a robust foundation of peer-reviewed animal trials, in-vitro tissue assays and non-human primate data. This page covers how it works, what the studies actually showed, and the kidney findings that stopped its development as a weight-loss drug.
Other peptide categories
Browse the rest of the Peptides Lab South Africa range by research goal.